Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Xultophy Patients nave to basal insulin or a GLP-1 agonist: starting dose is 10 units once daily Patients currently on basal insulin or a GLP-1 agonist: starting dose is 16 units once daily Maintenance: titrate dose up or down by 2 units once or twice weekly, depending on blood sugar goals Missed doses: resume dosing at the next scheduled dose
Finally, oxygen (the electron acceptor ) accepts electrons from the chain, undergoing reduction and forming water
What MEDVi includes vs what it does not Knowing exactly what you get, and what you do not get, prevents the kind of disappointment that fuels negative reviews
Common side effects include nausea, vomiting, diarrhea, constipation, bloating, gas and stomach pain
Oncologist (2018) 23:1624